IQVIA Holdings (IQV) Gets a Buy from Morgan Stanley
In a report released today, Tejas Savant from Morgan Stanley maintained a Buy rating on IQVIA Holdings (IQV – Research Report), with a price ...
IQVIA Holdings (IQV) Gets a Buy from RBC Capital
RBC Capital analyst Sean Dodge reiterated a Buy rating on IQVIA Holdings (IQV – Research Report) today and set a price target of $270.00. The ...
AstraZeneca's cancer drug tops list of new brands launched in 2024
Indicates growing incidence of cancer among Indian population; five out of top 20 new brand launches are cancer drugs ...
Pharmabiz8h
Lupin and Natco receive US FDA approval for generic Tracleer tablets for oral suspension
Lupin and Natco receive US FDA approval for generic Tracleer tablets for oral suspension: Our Bureau, Mumbai Monday, February 10, 2025, 15:45 Hrs [IST] Global pharma major Lupin L ...
PharmiWeb9h
Clinical Trials Market Size and Share Report - 2025 to 2034
Clinical Trials Market OverviewThe Clinical Trials Market report delivers crucial insights into the market's growth ...